PubMed Health⌕ Search

Biomedical subjects

Nathan Brown

Publications and source records attributed to Nathan Brown.

11 recordsLinked to original sources

A novel workflow for the inverse QSPR problem using multiobjective optimization.

A workflow for the inverse quantitative structure-property relationship (QSPR) problem is reported in this paper for the de novo design of novel chemical entities (NCE) in silico through the application of existing QSPR models to calculate multiple objectives, including prediction confidence measures, to be optimized during the de novo design process. Two physical property datasets are applied as case studies of the inverse QSPR workflow (IQW): mean molecular polarizability and aqueous solubility. The case studies demonstrate the optimization of molecular structures to within a property range of interest; the optimized structures are then validated against QSPR models that are generated from sets of alternative descriptors to those used in the IQW. The paper concludes with a discussion of the results from the case studies.

Least-Squares Analysis↗

On scaffolds and hopping in medicinal chemistry.

The molecular scaffold is an oft-cited concept in medicinal chemistry suggesting that the definition of what makes a scaffold is rigorous and objective. However, this is far from the case with the definition of a scaffold being highly dependent on the particular viewpoint of a given scientist. It follows, therefore, that the definition of scaffold hopping and, more importantly, the detection of what constitutes a scaffold hop, is also ill-defined and highly subjective. Essentially, it is agreed that scaffolds should be substantially different from each other, although significantly similar to each other, to constitute a hop. In the latter, the scaffolds must permit a similar geometric arrangement of functional groups to permit the mode of action. However, this leaves the paradox of how to describe both scaffold similarity and dissimilarity simultaneously. In this paper, the current statuses of scaffolds and scaffold hopping are reviewed based on published examples of scaffold hopping from the literature. An investigation of the degree to which it is possible to formulate a more rigorous definition of scaffolds and hopping in the context of molecular topologies is considered. These techniques are adapted from chemoinformatics to be applied in the design of new medicinal compounds.

Chemistry, Pharmaceutical↗

Virtual environment-based training simulator for endoscopic third ventriculostomy.

A virtual environment-based endoscopic third ventriculostomy simulator is being developed for training neurosurgeons as a standardized method for evaluating competency. Magnetic resonance (MR) images of a patient's brain are used to construct the geometry model, realistic behavior in the surgical area is simulated by using physical modeling and surgical instrument handling is replicate by a haptic interface. The completion of the proposed virtual training simulator will help the surgeon to practice the techniques repeatedly and effectively, serving as a powerful educational tool.

Computer Simulation↗

Exploiting QSAR methods in lead optimization.

Quantitative structure-activity relationship (QSAR) models play a key role in lead optimization, where the focus is on increased efficiency and lower attrition. When experimental data becomes rate limiting, a suitable model can bridge the experimental resource gap and direct investigation of a lead series toward productive lines. Technically, QSAR models can be readily generated and published to a wide community via the World Wide Web. We therefore focus this review on issues affecting model quality rather than on cataloguing models that are available. We also review the area of inverse QSAR, in which a model can be harnessed to semi-automated methods to provide an efficient way to explore vast areas of chemical space.

Models, Chemical↗

A chemoinformatics analysis of hit lists obtained from high-throughput affinity-selection screening.

The high-throughput affinity-selection screening platform SpeedScreen was recently reported by the Novartis Institutes for BioMedical Research as a homogeneous, label-free screening technology with mass-spectrometry readout. SpeedScreen relies on the screening of compound mixtures with various target proteins and uses fast size-exclusion chromatography to separate target-bound from unbound substances. After disintegration of the target-binder complex, the binder molecules are identified by their molecular masses using liquid chromatography/mass spectrometry. The authors report an analysis of the molecular properties of hits obtained with SpeedScreen on 26 targets screened within the past few years at Novartis using this technology. Affinity-based SpeedScreen is a robust high-throughput screening technology that does not accumulate frequent hitters or potential covalent binders. The hits are representative of the most commonly identified scaffold classes observed for known drugs. Validated SpeedScreen hits tend to be enriched on more lipophilic and larger-molecular-weight compounds compared to the whole library. The potential for a reduced SpeedScreen screening set to be used in case only limited protein quantities are available is evaluated. Such a reduced compound set should also maximize the coverage of the high-performing regions of the chemical property and class spaces; chemoinformatics methods including genetic algorithms and divisive K-means clustering are used for this aim.

Chromatography, High Pressure Liquid↗

The de novo design of median molecules within a property range of interest.

In this paper an application is presented of the median molecule workflow to the de novo design of novel molecular entities with a property profile of interest. Median molecules are structures that are optimised to be similar to a set of existing molecules of interest as an approach for lead exploration and hopping. An overview of this workflow is provided together with an example of an instance using the similarity to camphor and menthol as objectives. The methodology of the experiments is defined and the workflow is applied to designing novel molecules for two physical property datasets: mean molecular polarisability and aqueous solubility. This paper concludes with a discussion of the characteristics of this method.

Camphor↗

Replication of chimeric yellow fever virus-dengue serotype 1-4 virus vaccine strains in dendritic and hepatic cells.

ChimeriVax-dengue (DEN) viruses are live attenuated vaccine candidates. They are constructed by replacing the premembrane (prM) and envelope (E) genes of the yellow fever (YF) 17D virus vaccine with the corresponding genes from wild-type DEN viruses (serotypes 1-4) isolated from humans. In this study, the growth kinetics of ChimeriVax-DEN1-4 and parent viruses (wild-type DEN-1-4 and YF 17D) were assessed in human myeloid dendritic cells (DCs) and in three hepatic cell lines (HepG2, Huh7, and THLE-3). In DC, ChimeriVax-DEN-1-4 showed similar growth kinetics to their parent viruses, wild-type DEN virus (propagated in Vero cells), or YF 17D virus (peak titers ~3-4.5 log(10) plaque-forming units (PFU)/mL at 48-72 hours post-infection). Parent wild-type DEN-1-4 viruses derived from C6/36 mosquito cells did not show any growth at a multiplicity of infection of 0.1 in DCs, except for DEN-2 virus, which grew to a modest titer of 2.5 log(10) PFU/mL at 48 hours post-infection. ChimeriVax-DEN1-4 grew to significantly lower titers (2-5 log(10) PFU/mL) than YF 17D virus in hepatic cell lines THLE-3 and HepG2, but not in Huh7 cells. These experiments suggest that ChimeriVax-DEN1-4 viruses replicate similarly to YF-VAX in DCs, but at a lower level than YF 17D virus in hepatic cell lines. The lack of growth of chimeric viruses in human hepatic cells suggests that these viruses may be less hepatotropic than YF 17D virus vaccine in humans.

Aedes↗

Generation and display of activity-weighted chemical hyperstructures.

A chemical hyperstructure is a single graph representation of a set of molecules that minimizes the degree of structural redundancy in the data set. This paper describes the use of a genetic algorithm to generate an activity-weighted chemical hyperstructure (AWCH) by sequentially mapping each molecule in the data set to the hyperstructure and then assigning activity and inactivity frequency weights to the nodes and edges of the hyperstructure. Experiments with several data sets demonstrate the level of activity clustering in an AWCH.

Journal Article↗

A graph-based genetic algorithm and its application to the multiobjective evolution of median molecules.

In this paper we propose a novel graph-based genetic algorithm for the evolution of novel molecular graphs from a predefined set of elements or molecular fragments with an external objective function. A brief overview of existing genetic algorithm approaches in molecular design is provided followed by a description of our approach. The paper continues to suggest a novel application of this program to the multiobjective evolution of median molecules that are structurally representative of a set of objective molecules. We conclude with a summary of our initial results along with a discussion of a variety of improvements and applications of our approach.

Algorithms↗

Relationships between Molecular Complexity, Biological Activity, and Structural Diversity.

Following the theoretical model by Hann et al. moderately complex structures are preferable lead compounds since they lead to specific binding events involving the complete ligand molecule. To make this concept usable in practice for library design, we studied several complexity measures on the biological activity of ligand molecules. We applied the historical IC50/EC50 summary data of 160 assays run at Novartis covering a diverse range of targets, among them kinases, proteases, GPCRs, and protein-protein interactions, and compared this to the background of "inactive" compounds which have been screened for 2 years but have never shown any activity in any primary screen. As complexity measures we used the number of structural features present in various molecular fingerprints and descriptors. We found generally that with increasing activity of the ligands, their average complexity also increased, and we could therefore establish a minimum number of structural features in each descriptor needed for biological activity. Especially well suited in this context were the Similog keys and circular substructure fingerprints. These are those descriptors, which also perform especially well in the identification of bioactive compounds by similarity search, suggesting that structural features encoded in these descriptors have a high relevance for bioactivity. Since the number of features correlates with the number of atoms present in the molecule, also the number of atoms serves as a reasonable complexity measure and larger molecules have, in general, higher activities. Due to the relationship between feature counts and densities on one hand and biological activity on the other, the size bias present in almost all similarity coefficients becomes especially important. Diversity selections using these coefficients can influence the overall complexity of the resulting set of molecules, which has an impact on the biological activity that they exhibit. Using sphere-exclusion based diversity selection methods, such as OptiSim together with the Tanimoto dissimilarity, the average feature count distribution of the resulting selections is shifted toward lower complexity than that of the original set, particularly when applying tight diversity constraints. This size bias reduces the fraction of molecules in the subsets having the complexity required for a high, submicromolar activity. None of the diversity selection methods studied, namely OptiSim, divisive K-means clustering, and self-organizing maps, yielded subsets covering the activity space of the IC50 summary data set better than subsets selected randomly.

Drug Design↗

Introducing the consensus modeling concept in genetic algorithms: application to interpretable discriminant analysis.

An evolutionary statistical learning method was applied to classify drugs according to their biological target and also to discriminate between a compilation of oral and nonoral drugs. The emphasis was placed not only on how well the models predict but also on their interpretability. In an enhancement to previous studies, the consistency of the model weights over several runs of the genetic algorithm was considered with the goal of producing comprehensible models. Via this approach, the descriptors and their ranges that contribute most to class discrimination were identified. Selecting a bin step size that enables the average descriptor properties of the class being trained to be captured improves the interpretability and discriminatory power of a model. The performance, consistency, and robustness of such models were further enhanced by using two novel approaches that reduce the variability between individual solutions: consensus and splice modeling. Finally, the ability of the genetic algorithm to discriminate between activity classes was compared with a similarity searching method, while naïve Bayes classifiers and support vector machines were applied in discriminating the oral and nonoral drugs.

Algorithms↗